02:21 PM EDT, 09/15/2025 (MT Newswires) -- (Updates with the latest stock movement in the headline and first paragraph.)

Avita Medical ( RCEL ) shares were up over 43% in recent Monday trading after the company said it received CE Mark approval for its Recell Go device, enabling it to commence sales in Europe and other markets that recognize the conformity label.

The company said late Sunday that it will now roll out the device in select European countries, including Germany, Italy, and the UK, in collaboration with burn centers and clinical partners.

Recell Go helps doctors use a small sample of a patient's skin to create a cell suspension that promotes healing in burns and wounds, Avita said.

Price: 6.55, Change: +1.99, Percent Change: +43.53